sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Genetic Engineering Drug Market Scope And Analysis

  • Report Code : TIPRE00020932
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analisi del mercato dei farmaci di ingegneria genetica e dei concorrenti entro il 2025-2031

Buy Now

Genetic Engineering Drug Market Report Genetic Engineering Drug Market Size and Share Genetic Engineering Drug Market Scope and Analysis

Genetic Engineering Drug Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Tipo di prodotto
  • anticorpo monoclonale
  • eritropoietina umana ricombinante
  • interferone umano ricombinante
  • ormone umano della crescita ricombinante
  • insulina umana ricombinante
By Utilizzatori finali
  • Industrie farmaceutiche
  • Istituti accademici
  • Agricoltura
  • Altri
By Geografia
  • America del Nord
  • Europa
  • Asia-Pacifico
  • America centrale e meridionale
Regions and Countries Covered Nord America
  • Stati Uniti
  • Canada
  • Messico
Europa
  • Regno Unito
  • Germania
  • Francia
  • Russia
  • Italia
  • Resto Europa
Asia-Pacifico
  • Cina
  • India
  • Giappone
  • Australia
  • resto delAsia-Pacifico
America centrale e meridionale
  • Brasile
  • Argentina
  • Resto delAmerica Centrale e Meridionale
Medio Oriente e Africa
  • Sudafrica
  • Arabia Saudita
  • Emirati Arabi Uniti
  • Resto del Medio Oriente e Africa
Market leaders and key company profiles
  • Shanghai Lansheng Guojian Pharmaceutical
  • Biotech Pharmaceutical
  • GeneScience Pharmaceuticals
  • Beijing SL Pharmaceutical
  • Anhui Anke Biotechnology
  • 3SBio
  • Jiangsu Sihuan Bioengineering
  • Tonghua Dongbao Pharmaceutical
  • Shenzhen Neptunus Interlong Bio-Technique